ey0019.13-6 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19
A Rowlands
, A Deeb
, A Ladjouze
, RT Hamza
, SA Musa
, J Raza
, F Jennane
, A Abu-Libdeh
, JP Chanoine
, the GPED CAH Working Group
jchanoine@cw.bc.ca BMJ Global Health 2021;6:e007195. doi: 10.1136/bmjgh-2021-007195Brief Summary: This review found that access to oral fludrocortisone and hydrocortisone remains suboptimal in the WHO Eastern Mediterranean Region. Improvement requires a collaboration between health professionals, families of patients, health authorities, pharmaceutica...